Pretor S, Bartels J, Lorenz T, Dahl K, Finke J H, Peterat G, Krull R, Al-Halhouli A T, Dietzel A, Büttgenbach S, Behrends S, Reichl S, Müller-Goymann C C
Institut für Pharmazeutische Technologie, Technische Universität Braunschweig , Mendelssohnstraße 1, 38106 Braunschweig, Germany.
Mol Pharm. 2015 Jan 5;12(1):34-45. doi: 10.1021/mp500401t. Epub 2014 Nov 26.
In vitro studies of ocular bioavailability of active pharmaceutical ingredients (API) from colloidal drug delivery systems do not consider physiological shear stress generated by eyelid wiping and tear flow. The present study introduces a live cell imaging approach which enables the investigation of model drug uptake from various formulations under shear stress by using custom-made microchannels for the cultivation of human corneal epithelial cells (HCE-T). Coumarin-6 (C-6) was used as a model API incorporated into solid lipid nanoparticles and liposomes, and as an aqueous crystalline suspension. Confocal laser scanning microscopy visualized C-6 uptake into HCE-T cells in a time-resolved manner with an applied shear stress of 0.1 Pa. Static conditions were also studied for comparative purposes. Additionally, solid lipid nanoparticles (SLN) were labeled with a fluorescent phospholipid to check whether C-6 uptake was associated with SLN incorporation into the cells.
Intact SLN were not incorporated into the cells, i.e., C-6 was passively redistributed from SLN to lipophilic cellular compartments. C-6 was enriched up to a given limit in HCE-T cells within 5 min of contact with the dispersions both under static and under flow conditions. The C-6 delivery rate from liposomes was superior to that from SLN whereby the suspension exhibited the lowest rate. C-6 release rates were comparable for static and flow conditions. Alternate flushing with formulations and buffer revealed that cells accumulated C-6. The results suggest that combining microfluidics with live cell imaging provides a valuable option for in vitro studies of ocular drug delivery.
对来自胶体药物递送系统的活性药物成分(API)进行的眼部生物利用度体外研究未考虑眼睑擦拭和泪液流动产生的生理剪切应力。本研究引入了一种活细胞成像方法,通过使用定制的微通道培养人角膜上皮细胞(HCE-T),能够研究在剪切应力下各种制剂中模型药物的摄取情况。香豆素-6(C-6)用作模型API,被纳入固体脂质纳米粒和脂质体中,并制成水性结晶悬浮液。共聚焦激光扫描显微镜以时间分辨的方式可视化了在0.1 Pa的剪切应力作用下C-6进入HCE-T细胞的过程。为了进行比较,还研究了静态条件。此外,用荧光磷脂标记固体脂质纳米粒(SLN),以检查C-6的摄取是否与SLN进入细胞有关。
完整的SLN未进入细胞,即C-6从SLN被动重新分布到亲脂性细胞区室。在静态和流动条件下,与分散体接触5分钟内,C-6在HCE-T细胞中富集到给定限度。脂质体的C-6递送速率优于SLN,而悬浮液的速率最低。静态和流动条件下的C-6释放速率相当。用制剂和缓冲液交替冲洗表明细胞积累了C-6。结果表明,将微流控技术与活细胞成像相结合为眼部药物递送的体外研究提供了一个有价值的选择。